Human gut microbiota analysis of cystic fibrosis infants using metaproteomics

Area of Science:

• Microbiology
• Gastroenterology
• Metabolomics

Background:

• Cystic fibrosis (CF) is a genetic disorder affecting multiple organs, including the gut.
• The gut microbiome plays a crucial role in health and disease, particularly in early life.
• Early life gut microbiome alterations are implicated in CF pathogenesis.

Purpose of the Study:

• To investigate the gut microbial proteome in infants with cystic fibrosis.
• To characterize the metaproteomic profile of the infant gut microbiome in early-stage CF.
• To establish a baseline for future microbiome-based therapeutic strategies in pediatric CF.

Main Methods:

• Metaproteomic analysis of stool samples.
• Analysis of samples from eight infants with cystic fibrosis.
• Focus on the first year of life for each infant.

Main Results:

• First metaproteomic analysis of gut microbiota in infants with CF.
• Characterization of the protein landscape of the infant gut microbiome in CF.
• Identification of microbial protein signatures associated with early-life CF.

Conclusions:

• Metaproteomics offers a novel approach to studying the infant gut microbiome in CF.
• This study provides foundational data on the early-life gut microbial proteome in CF.
• Further research can leverage these findings to understand CF progression and develop interventions.